A Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; CEP of the European Pharmacopoeia monograph is often referred to as a Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; Certificate of Suitability (COS). The purpose of a Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; to their clients by showing that a Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; CEP has been issued for it. The manufacturer submits a Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; CEP (COS) as part of the market authorization procedure, and it takes on the role of a Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; CEP holder for the record. Additionally, the data presented in the Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; DMF.
A Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; suppliers with CEP (COS) on PharmaCompass.